A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin (Q43231308)
Jump to navigation
Jump to search
scientific article published on 3 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin |
scientific article published on 3 December 2009 |
Statements
1 reference
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin (English)
1 reference
M Ranson
1 reference
H Shaw
1 reference
J Wolf
1 reference
M Hamilton
1 reference
S McCarthy
1 reference
A Reid
1 reference
I Judson
1 reference
3 December 2009
1 reference
1 reference
66
1 reference
1
1 reference
53-58
1 reference
Identifiers
1 reference
1 reference